KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Descripción general
Resumen del artículo
The 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases provides updated recommendations for diagnosis, treatment, and special considerations for several glomerular diseases. The guideline emphasizes minimizing adverse effects from immunosuppression while maximizing patient comfort and prioritizing the use of lower cost therapies where available. Research recommendations for all disease entities are also given.
Explícamelo como si tuviera cinco años
This is like when doctors make a new rulebook to help kids with tiny kidney filters work better. They want to make sure the medicine doesn't make you too sick and use medicines that aren't too expensive.
Posibles conflictos de intereses
Several Work Group members disclosed potential conflicts of interest, including consultancy or grant/research support from pharmaceutical companies. The full disclosure statements can be found in the 'Biographic and disclosure information' section.
Limitaciones identificadas
Explicación de la calificación
The KDIGO 2021 guideline offers a comprehensive overview of clinical practice in glomerular diseases. It emphasizes a holistic approach, considering factors like patient comfort, medication costs, and side effects. However, the guideline also acknowledges limitations in current research and the need for more studies. Despite its limitations, the guideline provides valuable information for clinicians treating these diseases.
Conviene saber
Este es el análisis de Starter. Paperzilla Pro verifica cada cita, investiga los antecedentes de los autores y las fuentes de financiación, y utiliza razonamiento avanzado con IA para ofrecer información más exhaustiva.
Explorar Pro →